Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
August 29, 2007

FDA Approves Roche’s West Nile Virus Blood Screening Test

  • The FDA approved Roche’s BLA related to its test for direct detection of West Nile virus in donated human blood and plasma. West Nile can be transmitted by transfusion of infected blood or blood products.

    The test, called the cobas TaqScreen West Nile Virus Test, enables detection of the virus earlier in the infection cycle in donors who may show no symptoms of disease, according to the company.

    The test is designed to run on the cobas 201 system, Roche’s flexible, modular instrument platform that automates each step of the real-time PCR blood screening process. The test uses Roche’s PCR technology to detect the genetic material of the West Nile virus directly in blood.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.